1 / 5

FDA Advisory Committee Training

FDA Advisory Committee Training. An Industry Representative Perspective Alison Lawton Sr. VP Regulatory Affairs Genzyme Corporation. Background to Industry Representative. Introduced in FDA Modernization Act Non-voting member, non–SGE Financial interest disclosure Conflict of interest?

gudrun
Télécharger la présentation

FDA Advisory Committee Training

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. FDA Advisory Committee Training An Industry Representative Perspective Alison Lawton Sr. VP Regulatory Affairs Genzyme Corporation

  2. Background to Industry Representative • Introduced in FDA Modernization Act • Non-voting member, non–SGE • Financial interest disclosure • Conflict of interest? • Personal example

  3. Process for Nomination • Federal Register notice published • Industry organizations interested send a letter within 30 days • FDA requests organizations to consult in selecting candidate (if more than 1 identified) • Single nominee provided to FDA within 60 days

  4. How is the Industry Rep. Selected? • Industry Associations poll members for nominees • Nominees are reviewed by appropriate committee e.g. PhRMA RACC • Education, knowledge in subject, industry experience • Industry Associations agree on a single nominee • Nominee details sent to FDA

  5. What is the role of the Industry Rep.? • Represents global concerns for industry (not their own company) • Provide industry perspective to discussions e.g. cost or practical application of a proposal, regulatory standards • Speak with industry &/or sponsor before meeting to ensure appropriate representation

More Related